Emerging therapies for non-small cell lung cancer harboring EGFR exon 20 insertion mutations: narrative review

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR) exon 20 insertion mutations (ex20ins) are uncommon in non-small cell lung cancer (NSCLC). These mutations are generally resistant to first-generation EGFR tyrosine kinase inhibitors, unlike common EGFR mutations, including exon 19 del...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Naohiro, Horio, Yoshitsugu, Fujiwara, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816854/
https://www.ncbi.nlm.nih.gov/pubmed/36618815
http://dx.doi.org/10.21037/atm-2022-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816854/
https://www.ncbi.nlm.nih.gov/pubmed/36618815
http://dx.doi.org/10.21037/atm-2022-56

Ejemplares similares